On April 15, 2022, Christoph Lengauer, a member of the board of directors of HOOKIPA Pharma Inc. notified the Company that he will not stand for re-election to the Board when his term expires at the Company's 2022 annual meeting of shareholders on June 30, 2022. Dr. Lengauer's decision not to stand for re-election to the Board is not due to any disagreement with the Company. Dr. Lengauer will continue to serve as a member of the Board and a member of the Nominating and Corporate Governance Committee of the Board until the 2022 Annual Meeting, when his resignation will be deemed effective.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
0.98 USD | +14.34% | +14.09% | +20.99% |
05-09 | HOOKIPA Pharma Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024 | CI |
04-25 | Transcript : HOOKIPA Pharma Inc. - Special Call |
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
+20.99% | 96.97M | |
+37.74% | 723B | |
+34.69% | 595B | |
-2.07% | 369B | |
+20.25% | 332B | |
+2.99% | 282B | |
+17.21% | 244B | |
+9.99% | 208B | |
-4.13% | 205B | |
+7.43% | 166B |
- Stock Market
- Equities
- HOOK Stock
- News HOOKIPA Pharma Inc.
- HOOKIPA Pharma Inc. Announces Christoph Lengauer, A Member of the Board of Directors Will Not Stand for Re-Election